- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Poly-cyclodextrin-bis-cysteine-PEG3400-camptothec
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Poly-cyclodextrin-bis-cysteine-PEG3400-camptothecin-conjugate
| EU orphan designation number: | EU/3/17/1860
|
| Active ingredient: | Poly-cyclodextrin-bis-cysteine-PEG3400-camptothecin-conjugate |
| Indication: | Treatment of ovarian cancer |
| Sponsor: | Viadoc Business Solutions Limited
C/O Oakwood Corporate Services 1 Ashley Road, 3rd floor, Altrincham, Cheshire, WA14 2DT, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 22/03/2017 | Orphan designation | EMA/OD/300/16 | (2017)1988 of 20/03/2017 |
CONTACT
EU links
Directorate General Health & Consumers